LOBO EV Technologies Ltd. Announces Strategic Collaboration with Roundtree Lab, LLC to Manufacture Advanced E-Hospital Beds
22 Gennaio 2025 - 2:30PM
LOBO EV Technologies Ltd. (Nasdaq: LOBO) (“LOBO” or the “Company”),
an innovative e-bicycle, e-moped, e-tricycle, and electric
off-highway four-wheeled shuttle designer, developer, manufacturer
and seller, today announced that it entered into a letter of intent
with Roundtree Lab, LLC (“Roundtree”), a Wyoming hospital equipment
supplier, to manufacture smart electric medical transport beds.
This partnership marks LOBO’s first foray into the healthcare
equipment market, further underscoring the Company’s commitment to
innovation and diversification. The parties expect to enter into a
definitive agreement for this strategic collaboration.
The collaboration leverages LOBO’s extensive expertise in
connectivity and multimedia interactive systems—capabilities
historically applied to electric mobility design and
manufacturing—and applies them to Roundtree’s advanced bed
technology. By combining the patented AI solutions of Roundtree
with LOBO’s state-of-the-art manufacturing processes, the two
companies aim to improve patient care, safety, and efficiency
within healthcare facilities.
Key Highlights of the Collaboration
- OEM Manufacturing
Agreement
- LOBO will act as the
Original Equipment Manufacturer (OEM) for
Roundtree’s AI-driven medical transport beds, utilizing Roundtree’s
valuable patents and licenses.
- Market Expansion
- Roundtree’s relationships with U.S.
hospitals will accelerate market penetration for
these advanced transport beds across the United States.
- Revenue Potential
- The partnership is projected to
generate more than $10 million in revenue in 2025,
contingent on LOBO’s consistent delivery of high-quality products
and its proven manufacturing capabilities.
Management Commentary
Huajian Xu, CEO of LOBO, commented:
“We are thrilled to join forces with Roundtree Lab to deliver
AI-powered medical transport beds to the U.S.
healthcare market. This collaboration underscores our dedication to
creating cutting-edge products that offer exceptional value and
user experience—whether on the road or in a hospital setting.”
Gordon Franklin, CEO of Roundtree Lab,
added:
“LOBO’s proven manufacturing prowess and commitment to
technology innovation make them the ideal partner. We believe our
patented AI platform, combined with LOBO’s top-tier production,
will raise the bar for patient care and operational
efficiency in healthcare facilities.”
About LOBO EV Technologies Ltd.LOBO is an
innovative designer, developer, manufacturer and seller of
e-bicycles, e-mopeds, e-tricycles, and electric off-highway
four-wheeled shuttles such as golf carts and mobility scooters for
the elderly and disabled persons. LOBO also provides automobile
information and entertainment software development and design
services to customers. Leveraging its cutting-edge technologies in
connectivity, multimedia interactive systems and artificial
intelligence, LOBO re-defines and develops its products in order to
provide users with convenient, affordable and pleasant driving
experiences. For more information,
visit: https://www.loboebike.com and https://loboai.com. Any
information displayed on, or that can be accessed through, our
website or any other website or any social media is not a part of
this press release.
Forward Looking StatementsThis press release
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended (the “Securities
Act”) as well as Section 21E of the Securities Exchange Act of
1934, as amended, and the Private Securities Litigation Reform Act
of 1995, as amended, that are intended to be covered by the safe
harbor created by those sections. Forward-looking statements, which
are based on certain assumptions and describe the Company’s future
plans, strategies and expectations, can generally be identified by
the use of forward-looking terms such as “believe,” “expect,”
“may,” “will,” “should,” “would,” “could,” “seek,” “intend,”
“plan,” “goal,” “project,” “estimate,” “anticipate,” “strategy,”
“future,” “likely” or other comparable terms, although not all
forward-looking statements contain these identifying words. All
statements other than statements of historical facts included in
this press release regarding the expected closing date of the
public offering and the Company’s strategies, prospects, financial
condition, operations, costs, plans and objectives are
forward-looking statements. Important factors that could cause the
Company’s actual results and financial condition to differ
materially from those indicated in the forward-looking statements.
Such forward-looking statements are subject to risk and
uncertainties, including, but not limited to, those described in
“Risk Factors,” “Operating and Financial Review and Prospects,”
“Cautionary Note Regarding Forward-Looking Statements” in the
Annual Report on Form 20-F filed with the SEC (File No. 333-270499)
on April 30, 2024. LOBO undertakes no obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, after the date on which
the statements are made or to reflect the occurrence of
unanticipated events except as required by law. You should read
this press release with the understanding that our actual future
results may be materially different from what we expect.
Contact:For more information, contact:Zane XuIR
Managerir@loboai.com
Grafico Azioni LOBO EV Technologies (NASDAQ:LOBO)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni LOBO EV Technologies (NASDAQ:LOBO)
Storico
Da Feb 2024 a Feb 2025